The state of Illinois currently has 14 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Chicago, Peoria, Springfield and Urbana.
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Recruiting
The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days across the 3-month double-blind treatment period.
Gender:
ALL
Ages:
Between 12 years and 17 years
Trial Updated:
02/24/2025
Locations: St. Alexius Medical Center, Hoffman Estates, Illinois
Conditions: Chronic Migraine
The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.
Recruiting
A prospective study that investigates the impact of circadian rhythm disturbances due to daylight saving time transitions on migraine patients. The Primary aim is to investigate the impact of springtime DST (March 12 2023 at 2 AM on Sunday) on sleep metrics in patients with migraine headaches. Secondary aim is to examine the association between incidence of migraine headaches and sleep metrics with time transitions. Participants will be provided with a Withings non-wearable/contactless sleep t... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
02/15/2023
Locations: OSF HealthCare Saint Francis Medical Center, Peoria, Illinois
Conditions: Episodic Migraine